|

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

RECRUITINGSponsored by icometrix
Actively Recruiting
Sponsoricometrix
Started2024-03-01
Est. completion2027-04
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06280755

Summary

The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion criteria:

* Patients must have a confirmed diagnosis of MS, NMOSD, MOGAD, CIS or RIS.
* Patient (or patient's legal representative) has previously signed and dated an informed consent form (ICF) for the secondary use of their data, or assent form. Alternatively, the secondary use of the patient's data is allowed following Institutional Review Board (IRB)/Ethical Committee (EC) approval in accordance with national and local subject privacy regulations.

Exclusion criteria:

* Patients under 18 years of age will be excluded.
* Other unspecified reasons that, in the opinion of the Investigator or Joint Steering Committee, make the patient unsuitable for participation in the study.

Conditions5

Clinically Isolated SyndromeMultiple SclerosisMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseNMO Spectrum DisorderRadiologically Isolated Syndrome

Browse More Trials

Multiple Sclerosis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.